feed,title,long_url,short_url
Benzinga,"Seres Stops Enrollment In Melanoma Study, Deprioritizes Further Development",https://benzinga.com/general/biotech/21/03/20052065/seres-stops-enrollment-in-melanoma-study-deprioritizes-further-development,https://j.mp/2OCC0Go
